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HuR is a member of the Drosophila Elav protein fam-
ily that binds mRNA degradation sequences and pre-
vents RNase-mediated degradation. Such HuR-medi-
ated mRNA stabilization, which is stimulated by
integrin engagement and is controlled at the level of
HuR nuclear export, is critically involved in T-cell
cytokine production. However, HuR’s role in macro-
phage soluble factor production, in particular in re-
sponse to angiogenic stimuli, has not yet been estab-
lished. We show that the labile transcripts that
encode vascular endothelial growth factor and ma-
trix metalloproteinase-9 are stabilized when mu-
rine macrophages adhere to the 2 integrin ligand
intercellular adhesion molecule-1. This mRNA stabili-
zation response was absent in bone marrow–derived
macrophages obtained from conditional macro-
phage-specific HuR knockout mice. The microvascu-
lar angiogenic response to an inflammatory stimulus
(ie, subcutaneous polyvinyl alcohol sponge implanta-
tion) was markedly diminished in these macrophage
HuR knockout mice despite the equal levels of mac-
rophage localization to those observed in littermate
wild-type controls. Furthermore, blood flow recovery
and ischemic muscle neovascularization after femoral
artery ligation were impaired in the conditional mac-
rophage-specific HuR knockout mice. These resultsdemonstrate that dynamic effects on mRNA, mediated
by the RNA-binding and RNA-stabilizing protein HuR,
are required for macrophage production of angio-
genic factors, which play critical roles in the neovas-
cular responses to a variety of stimuli, including tis-
sue ischemia. (Am J Pathol 2012, 180:1751–1760; DOI:
10.1016/j.ajpath.2011.12.025)
Angiogenesis, including vasculogenesis and arteriogen-
esis, is a fundamental physiologic process required for
normal development, reproduction, wound repair, and
response to ischemia.1 It can also contribute to patho-
logic states, as in tumor angiogenesis.2 Inflammation,
broadly defined as the recruitment and localized function
of leukocytes, has recently been implicated as an angio-
genic trigger in response to tissue ischemia. Perivascular
inflammatory cells, most notably macrophages, can be
identified in tissues early after the onset of ischemia.3
They can be potent producers of angiogenic factors [eg,
vascular endothelial growth factor (VEGF), basic fibro-
blast growth factor, tumor necrosis factor-, and granu-
locyte-macrophage colony-stimulating factor], which
stimulate growth of neovessels.4
VEGF, in particular the predominant isoform VEGF-A,
is a major mediator of physiologic and pathophysiologic
angiogenesis.5 It is essential in many aspects of devel-
opmental vasculogenesis and tissue-responsive angio-
genesis. VEGF acts in a paracrine manner to stimulate
differentiation of VEGFR2 angioblasts and to promote
proliferation and survival of endothelial cells, thereby in-
ducing sprouting of new vessels.6 Transcription of the
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VEGF transcript is intrinsically labile. Consequently,
VEGF mRNA stabilization is an important regulatory point
in the modulation of VEGF gene expression.7
Steitz and colleagues8 first established the association
between mRNA degradation and HuR, a member of the
Drosophila Elav protein family. HuR binds to mRNA deg-
radation sequences, adenylate uridylate–rich elements
(AREs), in 3=-untranslated regions, thereby preventing
ARE-bearing transcripts from RNase-mediated degrada-
tion.9 VEGF is one such transcript. Its strong expression
in hypoxic states (including ischemia) is a consequence
of transcriptional induction and HuR-dependent mRNA
stabilization.10 Matrix metalloproteinase-9 (MMP-9) is
another HuR-regulated transcript. The ubiquitously ex-
pressed HuR, but not the Hu family relatives HuB, HuC,
and HuD, is the main constituent of complexes binding
to ARE motifs of MMP-9’s 3=-untranslated region.11
HuR has been implicated in a diverse array of immune
and inflammatory events owing to its apparent binding
to and stabilization of numerous inducible transcripts,
including those encoding interferon-, tumor necrosis
factor-, IL-8, IL-3, and the urokinase-type plasminogen
activator.12
During leukocyte recruitment and tissue localization,
largely chemokine driven, adhesion receptors must be
productively engaged to promote firm adhesion and
transmigration. Dynamically regulated leukocyte integ-
rins dominate this facet of inflammation. In addition to
their adhesive role, 2 integrins transduce transmem-
brane signaling events, resulting in a variety of kinase
cascades and activation of Rho family small G proteins.13
We previously demonstrated that engagement of the 2
integrin lymphocyte function–associated antigen-1
(LFA-1, also referred to as L, 2, and CD11a/CD18) in T
cells results in stabilization of ARE-bearing mRNAs en-
coding tumor necrosis factor- and interferon-. This oc-
curs through an induced, required, rapid nuclear-to-cy-
toplasmic translocation of HuR,14 mediated by a Vav-1/
Rac/p38 pathway.15 We hypothesized that 2 integrin
engagement in cells of the monocyte/macrophage lin-
eage can induce similar mRNA stabilizing signals. Fur-
thermore, we propose that these HuR modulatory events
are critical in angiogenic settings dependent on mono-
nuclear cell recruitment and production of angiogenic
factors.
In this work, we demonstrate that macrophage 2 in-
tegrin engagement results in HuR-dependent stabiliza-
tion of angiogenic factor–encoding VEGF and MMP-9
mRNAs. Furthermore, we targeted the murine HuR gene in
vivo and used a macrophage-specific (HuRfl/fl LysM-Cre)
HuR knockout (KO) to document a role for dynamic,
HuR-dependent, macrophage-mediated angiogenic fac-
tor production in two “inflammatory angiogenesis” mod-
els. We discuss the importance of monocyte/macro-
phage recruitment, adhesion, tissue localization, and
activation in angiogenic responses to a foreign body
[polyvinyl alcohol (PVA) sponge model] and tissue isch-
emia (hind limb ischemia model).Materials and Methods
Generation of Conditional HuR-KO
(HuRfl/fl LysM-Cre) Mice
Exon 2 of the Elavl1 gene, which encodes the start codon
of HuR, was flanked by loxp sites using homologous
recombination. A mouse genomic DNA BAC library (Ge-
nome Systems Inc., St. Louis, MO) was screened by PCR
to isolate a clone containing the Elavl1 gene. The BamHI/
EcoR1 restriction fragments were cloned into pEasyFlox
vector (Stratagene, Cedar Creek, TX) to generate the
targeting vector (see Supplemental Figure S1A at http://
ajp.amjpathol.org). This vector was linearized with SfiI and
was transfected into SvJ.129 mouse embryonic stem
cells. After selection with neomycin and gancyclovir, the
embryonic stem clones were transfected with a plasmid-
expressing Cre recombinase and were screened for ex-
cision of the neomycin cassette. The positive clones were
subsequently injected into C57BL/6 blastocysts for chimera
production. Mice with germline transmission of the floxed
Elavl1 allele (HuRfl) were crossed with the C57BL/6 back-
ground for at least six generations. The resulting mice were
intercrossed to generate homozygous HuRfl/fl mice,
herein referred to as wild-type (WT) controls. These mice
were further crossed with B6.129 P2-Lyz2tm1(cre)Ifo/J
mice16 (The Jackson Laboratory, Bar Harbor, ME) to gen-
erate HuRfl/fl LysM-Cre mice, herein referred to as KO
mice, which have a myeloid-specific conditional HuR de-
letion. All the mice were routinely screened for the pres-
ence of the HuRfl allele by PCR using primers flanking the
loxp site upstream of exon 2: 5=-GGATGACGGCAAT-
GACTAAAA-3= (F1) and 5=-TTTGGTTTGATTTGGTT-
GTTCTTG-3= (R1). Deletion of exon 2 in bone marrow–
derived macrophages (BMDMs) was verified by PCR
using the forward primer listed in the previous sentence
and another reverse primer, 5=-TTCAATTCCCTGCAAC-
CACAT-3= (R2), downstream of the second loxp site. The
presence of the LysMcre allele was verified by PCR fol-
lowing the protocol of The Jackson Laboratory.
Flow Cytometry
Fluorescence staining was performed on 2 to 5  105
cells following standard procedures. Data were acquired
using a FACSCalibur flow cytometer (BD Biosciences,
Franklin Lakes, NJ) and were analyzed using FlowJo
software version 9.3.2 (Tree Star Inc., Ashland, OR). The
following antibodies were used in the experiments: anti-
F4/80-A647 (eBioscience, San Diego, CA), anti-F4/80–
fluorescein isothiocyanate (eBioscience), phycoerithtin
anti-mouse CD11a (BD Pharmingen, Franklin Lakes, NJ),
phosphatidylethanolamine rat anti-mouse CD11b (eBio-
science), and phosphatidylethanolamine anti-mouse
CD18 (BD Pharmingen). For intracellular HuR staining,
cells were fixed with 4% paraformaldehyde, permeabil-
ized with saponin, and stained with mouse anti-HuR an-
tibody (clone 3A2; Santa Cruz Biotechnology, Santa
Cruz, CA) or mouse IgG1 isotype control labeled with
Zenon Alexa Fluor 488 anti-mouse IgG1 antibody (Invit-
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cytometer.
BMDM Isolation and Culture
BMDMs were obtained by in vitro differentiation of primary
bone marrow cells using an established protocol17 with
the minor variations noted herein. Briefly, femurs and
tibiae from WT and KO mice were isolated, cleaned,
disinfected in 70% ethanol for2 to 5 minutes, washed in
PBS, and ground in RPMI 1640 medium, followed by
serial washing and centrifugation in cold PBS. Bone mar-
row cells were then cultured at a density of 4  106
cells/mL in 30% L929 cell–conditioned medium and 70%
fully supplemented RPMI 1640 medium (Invitrogen). On
day 4, fresh medium containing L929 cell–conditioned
medium was added, after which cells matured into phe-
notypic macrophages over 7 days. Cells were recovered
with 1 mmol/L EDTA and vigorous pipetting. Flow cyto-
metric analysis confirmed that recovered cells were
97% F4/80, CD11b.
mRNA Decay Assay
RNA decay assays and real-time PCR were performed as
previously described.15 A total of 4.5  106 cells/mL of
the murine macrophage cell line Raw 264.7 or primary
BMDMs (WT or KO) was resuspended in the divalent
cation–containing “integrin activation buffer” [100
mmol/L Tris-HCl (pH 7.5), 0.9% NaCl, 2 mmol/L MnCl2, 2
mmol/L MgCl2, 5 mmol/L D-glucose, and 1.5% bovine
serum albumin] and was plated onto dishes coated with
either 0.1 ng/mL recombinant mouse intercellular adhe-
sion molecule 1 (ICAM-1)–Fc (R&D Systems, Minneapo-
lis, MN) or, as a negative control, 20 mg/mL poly-L-lysine
(Sigma-Aldrich, St. Louis, MO). At 30 minutes, the integrin
activation buffer was replaced with RPMI 1640 medium/
10% fetal bovine serum containing 1 nmol/L Phorbol 12-
myristate 13-acetate (PMA) to trigger transcription. This
concentration of PMA was in all the experimental samples
and controls and never, alone, promoted mRNA stabili-
zation. After 2.5 hours (37°C), 0.5 mmol/L 5,6-dichloro-1-
-D-ribobenzimidazole (DRB) (Sigma-Aldrich) was
added to arrest transcription. This was considered time 0
in decay assays. Cells were harvested at the indicated
time points, and RNA was harvested for analysis by
quantitative PCR. mRNA levels at time 0 were designated
100%, to which each subsequent time point mRNA level
was compared. In some experiments, the effect of 2
integrin blockade on induced mRNA stabilization was
assessed. Isolated BMDM Fc receptors were first blocked
with 0.5 g/107 cells of anti-CD16/CD32 monoclonal anti-
body (eBioscience) on ice for 15 minutes, followed by sat-
urating concentrations of anti-CD8 monoclonal antibody
(clone 53–6.72, IgG2a isotype control), anti-CD11a (clone
M17/4.4.11.9, IgG2a), or anti-CD11b (clone M18/2.a.12.7,
IgG2a) on ice for 60 minutes. Excess antibody was
washed out, and the cells were resuspended in integrin
activation buffer, after which the decay assay proceeded
as described previously herein.Quantitative Real-Time PCR
Total RNA was isolated from cells using the RNeasy mini
kit (Qiagen, Germantown, MD) and 1-g was reverse
transcribed using an iScript cDNA synthesis kit (Bio-Rad
Laboratories, Hercules, CA), according to the manufac-
turer’s protocols. The resulting cDNA template was sub-
jected to real-time PCR analysis by a QuantiTect SYBR
Green PCR kit (Qiagen) using an Opticon DNA Engine 2
(MJ Research, Waltham, MA) and the following cycling
parameters: 95°C for 15 minutes, then 50 cycles of 95°C
for 15 seconds, 56°C for 30 seconds, and 72°C for 30
seconds. VEGF and MMP-9 mRNA levels were normal-
ized to -actin levels for each sample run in duplicate.
Sequences of primers used in quantitative real-time PCR
were all synthesized by the Keck Biotechnology Resource
Facility at Yale University (New Haven, CT) as follows:
VEGF, 5=-GGAGATCCTTCGAGGAGCACTT-3= (sense) and
5=-GGCGATTTAGCAGCAGATATAAG; AA-3= (antisense);
MMP-9, 5=-CGTCGTGATCCC-CACTTACT-3= (sense) and
5=-AACACACAGGGTTTGCCTTC-3= (antisense); and actin,
5=-GTGGGCCGCTCTAGGCACCAA-3= (sense) and 5=-TG-
GCTTTAGGGTTCAGG-GGG-3= (antisense).
ELISA
VEGF levels were measured in supernatants from cul-
tures of BMDMs after 0.5-, 12-, and 24-hour adhesion to
ICAM-1– or control poly-L-lysine–coated dishes. VEGF
protein was measured by enzyme-linked immunosorbent
assay (ELISA) according to the manufacturer’s instruc-
tions (PeproTech Inc., Rocky Hill, NJ). VEGF concentra-
tions were normalized to cell number (per 1.5 106 cells)
and were run in triplicate.
PVA Sponge Implant Model
Two subcutaneous dorsolateral pockets were created
through 1.25-cm incisions, each into which a 2-mm-thick,
6-mm-diameter sterile PVA sponge (Ultra Medical Tech-
nologies Inc., North Stonington, CT) was inserted.
Sponges were harvested at the indicated time points with
collagenase digestion for cell [fluorescence-activated
cell sorting (FACS)] analysis and VEGF or MMP-9 RT-
PCR; frozen section 4% paraformaldehyde fixation (6-m
sections) for VEGF, MMP-9, and F4/80 immunofluores-
cence; or zinc fixation and paraffin embedding (5-m
sections) for tetrarhodamine isothiocyanate–labeled lec-
tin (Bandeiraea simplicifolia 1; Sigma-Aldrich) staining.
Hind Limb Ischemia Model
After anesthesia with ketamine and xylazine, the proximal
and distal portions of the femoral artery were ligated, and
the distal portion of the saphenous artery was ligated or
cauterized, as were all the branches in these ligated
segments. Contralateral sham operations of skin incision
without femoral artery ligation were performed for control.
A deep, penetrating laser Doppler probe (PeriFlux Sys-
tem; Perimed Inc., North Royalton, OH) was placed di-
rectly on the gastrocnemius muscle before and after li-
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initial flow measurements repeated at 3 days and at
1-week intervals to 4 weeks. Laser Doppler imaging flow
results are expressed as the ratio of ischemic to nonis-
chemic (contralateral) hind limb perfusion to avoid the
influence of ambient light and temperature. A clinical
scoring system was used for limb mobility and tissue
injury as previously defined.18 At 4 weeks, gastrocnemius
and soleus muscles from the ischemic and nonischemic
control limbs were harvested, zinc fixed, and paraffin
embedded. Sections, 5 mol/L, were stained with tetrar-
hodamine isothiocyanate–labeled lectin, as described
previously herein. In addition, hind limb muscles (gas-
trocnemius and soleus) were harvested at the indicated
time points, and collagenase was digested to obtain cells
for FACS analysis.
Immunofluorescence and Morphometry
HuR immunofluorescence and its morphometric assay,
have been previously described.15 WT BMDMs were
treated with integrin activation buffer for 60 minutes on
coverslips coated with either 0.1 ng/mL recombinant
mouse ICAM-1–Fc (R&D Systems) or, as a negative con-
trol, 20 mg/mL poly-L-lysine (Sigma-Aldrich). Adhered
cells were fixed with 4% paraformaldehyde for 15 min-
utes at 4°C and were subsequently permeabilized with
0.1% Triton X-100 (Roche Diagnostics GmbH, Mann-
heim, Germany), followed by blocking with 5% goat se-
rum overnight at 4°C. Cells were immunostained with 5
g/mL anti-HuR overnight at 4°C and were co-stained
with 0.005% DAPI (Invitrogen). For the morphometric as-
say, 20 cells from each condition in three different fields
were included in the analysis. The ratio of HuR translo-
cation was calculated as the area visible with anti-HuR
antibodies in the cytoplasm plus the nucleus divided by
the nuclear area (by DAPI staining for nuclear definition).
ImageJ software version 1.32j (NIH, Bethesda, MD) was
used to determine the areas.
Animal Studies
All the animal studies were approved by the Institu-
tional Animal Care and Use Committee of Yale Univer-
sity. For all the procedures on live mice, the animals
were anesthetized i.p. with ketamine (80 mg/kg) and
xylazine (10 mg/kg).
Statistical Analysis
Statistical significance was determined by two-way anal-
ysis of variance (ANOVA) followed by a Bonferroni post-
test for multiple comparisons or by an unpaired t-test
using GraphPad Prism software version 5.01 (GraphPad
Software Inc., San Diego, CA). Minimum levels of signif-
icance were set at P  0.05.Results
Targeting of HuR Genes and Characterization of
Conditional KO Macrophages
To obtain macrophages with conditional deletion of HuR,
we flanked exon 2 of the Elav1 gene with loxp sites (see
Supplemental Figure S1A at http://ajp.amjpathol.org) and
crossed the resulting HuRfl mice with LysM-Cre mice.
Expression of Cre recombinase driven by the LysM pro-
moter resulted in deletion of exon 2 encoding the start
codon of HuR in differentiated BMDMs, as evidenced by
the product in the PCR with the reverse primer R2 (see
Supplemental Figure S1B at http://ajp.amjpathol.org). Al-
though some of the genomic DNA remained intact (see
Supplemental Figure S1B at http://ajp.amjpathol.org),
quantitative real-time PCR analyses of the genomic DNA
from BMDMs confirmed that the efficiency of deletion
approached 95%. BMDMs and splenic lymphocytes
were isolated from HuRfl/fl LysM-Cre (designated KO)
and HuRfl/fl (littermate control, designated WT) mice. Im-
munoblotting revealed effective and specific HuR dele-
tion in gene-targeted BMDMs (Figure 1A). Total spleno-
cyte HuR was only minimally reduced, and none of the
AUF-1 (another RNA-binding protein) isoforms were af-
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Figure 1. Characterization of conditional HuR KO macrophages. A: Lysates
obtained from BMDMs and total splenocytes isolated from KO (HuRfl/fl
LysM-Cre) and littermate WT control (HuRfl/fl) mice were immunoblotted
with anti-HuR or anti-AUF1 antibodies. B: BMDMs isolated from KO and WT
control mice were fixed and permeabilized, followed by intracellular HuR
staining with anti-HuR or mouse IgG1 isotype control and Zenon labeling
FITC-conjugated secondary antibody. Five thousand events were FACS-ana-
lyzed per sample. C: KO and WT control BMDMs were FACS-analyzed for
surface CD11a, CD11b, and CD18 expression. Five thousand events were
acquired per sample. Data are representative of cells obtained from four
different mice.
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pression confirmed the loss of HuR protein in KO BMDMs
(Figure 1B). Furthermore, maintenance of surface 2 in-
tegrin expression in KO BMDMs was documented (Fig-
ure 1C), indicating equivalent levels of LFA-1 and Mac-1
in macrophages derived from WT and KO mice.
To prevent the creation of a lysozyme M–deficient an-
imal, mice with the Cre gene inserted into only one allele
of lysozyme M were always used. Use of the lysozyme M
promoter to direct macrophage-specific expression of a
transgene has been widely discussed. Issues related to
timing of promoter activation and specificity are relevant.
Neutrophils express lysozyme M. As such, LysM-driven
Cre expression can result in neutrophil gene deletion.16
The HuRfl/fl LysM-Cre mice used in the present studies
had only a mild reduction in neutrophil HuR. Circulating
monocytes had intermediate levels, whereas tissue
macrophages and BMDMs always had much lower
levels of HuR. Recent lineage ablation models using
LysM-Cre/DTR mice demonstrate much greater deple-
tion of macrophages than do either neutrophils or cir-
culating monocytes.19 Furthermore, the angiogenesis
models we used are much more macrophage than
neutrophil dependent.
Effect of 2 Integrin Engagement and HuR Gene
Deletion on Angiogenic Factor Gene Expression
We previously showed that T-cell LFA-1 engagement re-
sults in rapid nuclear-to-cytosolic HuR translocation and
that this correlates with labile cytokine mRNA stabiliza-
tion.14,15 HuR translocation induced by other stimuli, in-
cluding heat shock, correlates with ARE-bearing tran-
script stabilization as well.20 To determine whether 2
integrin engagement similarly triggers HuR translocation
in cells of the monocyte/macrophage lineage, WT
BMDMs were plated on ICAM-1 or poly-L-lysine for 60
minutes, after which HuR immunofluorescence was per-
formed. Figure 2A demonstrates a complete overlap of
DAPI and HuR in control adhered cells. In contrast, BM-
DMs adhered to ICAM-I displayed significant extranu-
clear localization of HuR, shown quantitatively in Figure
2B. Given previous correlations, this result directed the
analysis of integrin-stimulated, HuR-dependent effects
on labile mRNA decay in macrophages.
VEGF-A is a key angiogenic factor. Its mature tran-
script is ARE bearing, intrinsically labile, and known to be
stabilized by HuR binding.10 MMP-9 is a zinc-containing
endopeptidase family member involved in extracellular
matrix degradation and vascular remodeling.21 MMP-9,
provided by bone marrow–derived cells, has been
shown to initiate the angiogenic switch, most notably in
tumor angiogenesis.22 The MMP-9 transcript also has
AREs in its 3=-untranslated region, although dynamic reg-
ulation of its decay and HuR dependence has not been
well characterized. To determine whether 2 integrin en-
gagement promotes angiogenic factor mRNA stabiliza-
tion, we first performed RNA decay experiments with the
immortalized murine macrophage line Raw 264.7. Cells
were adhered to either immobilized 2 integrin ligandrecombinant ICAM-1 or the polycation control poly-L-
lysine. After 30 minutes of adherence, PMA at a low
concentration (1 nmol/L) was added to enhance tran-
scription, which was allowed to proceed for 3 hours. The
RNA polymerase II inhibitor DRB was then added, and
RNA was recovered at multiple time points. Figure 3, A
and B, demonstrates that in control poly-L-lysine–ad-
hered cells, VEGF and MMP-9 mRNA decay to 50% of
time 0 levels at 40 minutes. In contrast, adherence onto
ICAM-1, ie, 2 integrin engagement, results in stabiliza-
tion of both transcripts. This integrin-induced VEGF and
MMP-9 mRNA stabilization was also observed in primary
murine macrophages obtained from WT but not macro-
phage HuR KO mice (Figure 3, C and D). That is, the 2
integrin–stimulated VEGF and MMP-9 transcript stabi-
lization is lost in the absence of HuR. Figure 3E dem-
onstrates the functional significance of this induced
extended mRNA half-life. As expected, VEGF protein,
as measured by ELISA, accumulated in supernatants
of integrin-engaged WT macrophages (threefold at
24 hours) but minimally in WT cells on poly-L-lysine or
KO macrophages on ICAM-1. These data demonstrate
that transmembrane integrin signaling drives the sta-
bilization of labile, proangiogenic mRNAs in macro-
phages and that this posttranscriptional event is HuR
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Figure 2. Effect of macrophage 2 integrin engagement on HuR transloca-
tion. A: WT BMDMs were adhered to ICAM-1– or control poly-L-lysine–
coated coverslips at 37°C for 60 minutes. Cells were fixed and permeabilized,
and immunofluorescent co-staining was performed with anti-HuR and with
DAPI for nuclear definition. Individual images were overlaid, and merges are
displayed as noted. Scale bar  5 m. B: Quantitative analysis of HuR
nuclear-to-cytosolic translocation. HuR translocation was expressed as the
ratio of HuR immunofluorescent plus nuclear area divided by the nuclear
area only, analyzed by ImageJ software version 1.32j. Twenty cells were
analyzed per experimental sample. The data are presented as mean  SEM.
***P  0.001 by ANOVA.dependent.
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Inflammatory Angiogenesis in Vivo
Little is known about HuR-dependent mechanisms regu-
lating angiogenic factor mRNA in vivo. We focused on
angiogenesis models that we believe to depend, in part,
on the recruitment of mononuclear leukocytes. As such,
we used a PVA sponge implantation mouse model, which
exhibits many features of wound healing, including
monocyte/macrophage localization of microvessel forma-
tion. On days 7, 10, and 14 after subcutaneous implan-
tation, PVA sponges were excised and evaluated for leu-
kocyte localization, VEGF and MMP-9 mRNA expression,
Figure 3. HuR requirement in 2 integrin–induced angiogenic factor gene
expression (mRNA stabilization and protein production). A and B: Raw 264.7
macrophages were stimulated with 1 ng/mL PMA to induce gene transcrip-
tion and adhesion and were plated on ICAM-1– or poly-L-lysine–coated
plates for 3 hours, after which 0.25 mmol/L DRB was added and mRNA was
recovered at 0, 20, and 40 minutes. VEGF (A) and MMP-9 (B) mRNA levels,
normalized to -actin, were determined by quantitative RT-PCR and are
expressed relative to time 0 (the time of DRB addition). Samples were
analyzed in triplicate, and the data are presented as mean  SEM. One
representative of three independent experiments is shown. C and D: BMDMs
isolated from WT and KO mice were adhered to ICAM-1– or poly-L-lysine–
coated plates for 3 hours, after which they were transcription arrested with
0.25 mmol/L DRB and RNA was harvested at 0, 30, or 60 minutes for VEGF
and MMP-9 quantitative RT-PCR analysis. VEGF (C) and MMP-9 (D) mRNA
levels were normalized to -actin and are expressed relative to time 0 (the
time of DRB addition). Data are presented as the combined mean  SEM of
three separate experiments. E: BMDMs from WT and KO mice were plated
on ICAM-1– or poly-L-lysine–coated plates and were cultured in supple-
mented RPMI 1640 medium with 2.5 ng/mL macrophage colony-stimulating
factor for 0.5, 12, and 24 hours. VEGF levels in the supernatant from the
indicated time points were determined by ELISA. Data are displayed as
mean  SEM VEGF level for three separate experiments. **P  0.01, ***P 
0.001 by ANOVA.and angiogenesis. Flow cytometric analysis demon-strated equal percentages of macrophages (F4/80) ex-
tracted from excised sponges in WT and KOmice (Figure
4B). Total cell numbers extracted were similar, indicat-
ing nearly identical numbers of macrophages localized
to PVA sponges in WT and KO mice. Macrophages
recovered from KO PVA sponges were, indeed, HuR
deleted, as determined by flow cytometric intracellular
HuR analysis (Figure 4D). Immunofluorescent micro-
graphs confirmed the lack of a defect in macrophage
localization to sponges in macrophage HuR KO mice
(Figure 4, A and E). However, there was substantially
less detectable VEGF and MMP-9 observed in these
micrographs (Figure 4, A and E, respectively). Of note
is that merged images displayed mostly detectable
VEGF and MMP-9 in and around F4/80 cells. This
finding supports the concept that recruited mononu-
clear leukocytes are the primary sources of the angio-
genic factors VEGF and MMP-9 in this model. Levels of
VEGF and MMP-9 mRNA, extracted from excised
sponges and analyzed by quantitative PCR, confirmed
a significant reduction in KO sponges at 2 weeks and
3 days, respectively (Figure 4, C and F). Most impor-
tant, there was a dramatic reduction in endothelial-
specific lectin reactivity and, therefore, microvessel
formation in sponges excised from macrophage HuR
KO mice (Figure 4G, with quantification in Figure 4H).
This correlated with a reduction in CD45, CD31 (en-
dothelial) cells extracted from excised KO sponges at
all time points tested (see Supplemental Figure S2 at
http://ajp.amjpathol.org). These results demonstrate
that monocyte/macrophages are the primary source of
the angiogenic factors VEGF and MMP-9 in this inflam-
matory angiogenesis model and that macrophage
HuR-dependent posttranscriptional mechanisms are
required for neovessel formation.
Clearly, other cells produce VEGF in response to
wounding. However, the present data are consistent with
those generated in wound repair models in which mac-
rophages have been selectively depleted.23 In the ab-
sence of macrophages, neovascularization is disturbed
and overall wound healing is impaired.
Effect of Macrophage-Specific HuR Gene
Deletion on Flow Recovery to Hind Limb
Ischemia
Numerous studies support at least a role for the recruit-
ment and localization of bone marrow–derived cells in
adaptive responses to tissue ischemia.24 To determine
whether the defects in inflammatory angiogenesis, de-
scribed previously herein, are relevant in more widely
applicable and relevant pathologic models, femoral ar-
tery ligation with consequent hind limb ischemia was
performed in WT and macrophage-specific HuR KO
mice, following which the indices of angiogenesis, blood
flow, and clinical scoring were examined. A deep, pene-
trating laser Doppler probe was used to measure gas-
trocnemius blood flow immediately, 3 days, and 1, 2, 3,
and 4 weeks after ligation in the ischemic and control
contralateral nonischemic hind limbs. Significant attenu-
iraea sim
1 by AN
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AJP April 2012, Vol. 180, No. 4ation of blood flow recovery was observed in the macro-
phage HuR KO mice compared with in WT controls (Fig-
ure 5A). This correlated well with clinical recovery.
Ischemic hind limbs became paretic in WT and KO mice
and largely recovered function over a 4-week period in
WT, but not in KO, mice. Figure 5B displays a much
greater degree of necrosis at 2 weeks in the paws of KO
mice compared with those of WT mice. This finding is
quantified using the clinical scoring system18 in Figure
5C. Furthermore, capillary number per muscle fiber, as
determined by endothelial-specific lectin reactivity, was
significantly lower in hind limb muscle (gastrocnemius
and soleus) obtained from macrophage HuR KO mice
compared with from WT controls 4 weeks after ligation
(Figure 5D, with quantification in Figure 5E). There were
no differences in baseline or nonischemic muscle capil-
lary (Figure 5, D and E) density. This difference was not
due to impaired recruitment and localization to ischemic
muscles as there were equal numbers of F4/80 cells in
WT and KO ischemic muscle (see Supplemental Figure
S3A at http://ajp.amjpathol.org, with quantification in Sup-
plemental Figure S3B) and there were equal percentages
of macrophages (F4/80) extracted from excised hind
limb muscle in WT and KO mice by flow cytometric anal-
ysis (see Supplemental Figure S3C at http://ajp.
amjpathol.org, with quantification in Figure 5F). These
data demonstrate that dynamic posttranscriptional mech-
anisms, specifically in macrophages, play a major role in
neovessel formation and flow recovery in acutely isch-
A
VEGF F4/80 Merge
W
T
K
O
%
 o
f M
ax
B
K
O
W
T
Day 7 Day 10 D
F4/80-A647
F4/80-AIgG1-A647
E
W
T
K
O
F4/80 MMP-9 Merge
F
Figure 4. Effect of macrophage HuR gene deletion on inflammatory angio
macrophage HuR KO (HuRfl/fl LysM-Cre) or WT (HuRfl/fl) mice, sponges
(F4/80) and the production of VEGF, with notable digitally merged images
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displayed as fold increase over 3-day KO level, defined as 1.0. Data are mea
sponges were excised 4 weeks after implantation. Cells were recovered by
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The mRNA-binding Hu family proteins are involved in a
diverse array of biological processes, including neuronal
differentiation and plasticity. HuR is ubiquitously ex-
pressed and has been convincingly demonstrated to
play a pivotal role in cellular stress responses.25 It pro-
vides a dynamic level of gene expression control from
effects on RNA splicing to translation.26 This includes
labile mRNA half-life extension, allowing a burst of tran-
script accumulation and consequent protein production.
This is highly relevant not only in development but also in
adaptive responses to metabolic, immune/inflammatory,
and ischemic perturbations.
Ischemic neovascularization, including microvessel
angiogenesis and arteriogenesis, is a complex process
requiring contributions of numerous growth factors, cyto-
kines, and proteases, including VEGF, placental growth
factor, fibroblast growth factor, insulinlike growth factor 1,
granulocyte colony-stimulating factor, granulocyte-mac-
rophage colony-stimulating factor, angiopoietins, and
MMPs.27–29 The relative importance of a given soluble
factor depends on the exact context, including the stim-
ulus and target tissue. VEGF is the prototype angiogenic
factor that is involved, to some degree, in most neovas-
cular responses. It is hypoxia/ischemia stimulated, is en-
coded by a very labile transcript(s) that is known to be
HuR bound, and can be produced by inflammatory cells.
MMP-9 is a zinc-dependent metalloproteinase involved in
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AJP April 2012, Vol. 180, No. 4angiogenesis and vascular remodeling. MMP-9 has been
shown to be important in regulating smooth muscle cells
function such that silencing MMP-9 gene expression in-
hibits smooth muscle cells migration.30 The present in
vitro data demonstrate macrophage 2 integrin–stimu-
lated, HuR-dependent stabilization of the VEGF and
MMP-9 transcripts. Furthermore, the reduction in VEGF
A
D
K
O
W
T
Non-ischemic Ischemic
BS1-Lectin
WT KO
C
FE
B
Figure 5. Effect of macrophage HuR gene deletion on blood flow recovery
to hind limb ischemia. A: Left femoral artery ligation or sham contralateral
surgery was performed on WT (HuRfl/fl) and HuR KO (HuRfl/fl LysM-Cre)
mice (n 6 in each experimental group). Laser Doppler imaging assessment
of gastrocnemius blood flow was performed before (Pre-OP), immediately
after (Post-OP), and at the indicated time points after ligation. Data are
expressed as a ratio of the left (ischemic) to right (control) limb perfusion 
SEM. n  6 animals per experimental group. *P  0.05, ***P  0.001 by
ANOVA. B: Photographs of paws distal to femoral artery ligation at 2 weeks
in WT and HuR KO mice, with severity of necrosis (black) displayed. C:
Clinical scoring of ischemic hind limbs in WT and HuR KO mice at the
indicated time points. As an index of limb ischemia severity, scores are
designated as follows: 0, normal; 1, pale foot and/or gait abnormalities; 2,
less than half of paw necrotic; 3, more than half of paw necrotic without
lower limb necrosis; and 4, more than half of paw necrotic with some lower
limb necrosis. Data are expressed as mean  SEM, n  6 per experimental
group. ***P  0.01 by ANOVA. D: Photomicrographs of endothelial-specific
lectin staining from representative sections of gastrocnemius and soleus
muscles 4 weeks after femoral artery ligation in WT and HuR KO mice. Scale
bar  80 m. E: Per lectin staining, quantitative data are presented as
capillary density or number per muscle fiber, which was counted in eight
randomly selected fields from three to four sections per mouse in each
experimental group (n  3 animals per group). Data are expressed as
mean  SEM. *P  0.05 by ANOVA. F: Quantification of macrophage
localization to ischemic muscle. Gastrocnemius and soleus muscles were
excised at the indicated time points, and cells extracted by collagense diges-
tion were phenotyped by FACS for macrophages (F4/80). Five thousand
events were acquired per sample, with histograms displaying the percentage
of F4/80-positive cells (mean  SEM) in each experimental group (n  3
animals per group).and MMP-9 (RNA and protein) in both angiogenesis mod-els, when using the macrophage-specific HuR gene–
deleted mouse, with a correlative impairment in neovas-
cularization, not only documents the importance of the
aforementioned posttranscriptional mechanisms in these
responses but also defines recruited inflammatory cells
as critical producers of soluble factors contributing to
angiogenesis. This adds mechanistic data to the long-
standing notion that macrophages play an important role
in wound repair.31 Recent work has carefully quantified
the contributions of macrophages to distinct phases of
wound repair, some of which include an angiogenic re-
sponse.23,32,33
ICAM-1 is the most widely expressed ligand for 2
integrins, productively engaging LFA-1 and Mac-1. In the
context of wound healing and angiogenesis, ICAM-1 is
basally expressed on all endothelial cells, as well as on
fibroblasts and melanocytes. Its expression is induced or
up-regulated in ischemic muscle cells,34 in viable myo-
cardium on the border zone of infarcted heart muscle,35
and in many cells in the setting of inflammatory cytokine
release. In the present models, it is likely that basal and
induced ICAM-1 expressed in capillary and postcapillary
venular endothelium engages monocyte/macrophage 2
integrin, promoting firm adhesion and transmigration and
triggering the critical signal transduction resulting in the
noted posttranscriptional regulatory responses. Few T
lymphocytes express Mac-1 (CD11b/CD18). As such,
our previous ICAM-1–binding, integrin-engagement ex-
periments clearly reflected LFA-1 transmembrane signal-
ing. Macrophages express high levels of LFA-1 and
Mac-1. Interaction between LFA-1 and ICAM-1 occurs
through LFA-1’s insertion domain and ICAM-1’s first Ig-
like domain.36 In contrast, Mac-1’s insertion domain in-
teracts with ICAM-1’s first Ig-like domain.37 Given this
difference, it is possible that one of these two interactions
more productively stimulates the kinase cascade known
to result in HuR translocation. Supplemental Figure S4
(available at http://ajp.amjpathol.org) demonstrates that
anti-CD11a, but not anti-CD11b, monoclonal antibody
efficiently blocks ICAM-1–stimulated BMDM VEGF mRNA
stabilization, suggesting that, as in T cells, engagement
of LFA-1 drives the HuR-dependent mRNA stabilization
response.
The role of 2 integrins in chemokine-driven leukocyte
recruitment, adhesion, and transmigration has been ex-
tensively studied. Using a similar hind limb ischemia
model, Chavakis et al38 previously demonstrated signifi-
cantly impaired limb perfusion recovery in 2 integrin
gene–deleted mice compared with in WT controls. In the
present work, HuR conditional KO macrophages ex-
pressed typical membrane levels of LFA-1 (Figure 1C)
and adhered normally to the 2 integrin ligand ICAM-1
(data not shown). Consistent with this, equal numbers of
HuR KO and WT macrophages were recruited and local-
ized to responsive tissues in both of the in vivo models.
Given the dramatic reduction in macrophage 2 integrin–
stimulated VEGF and MMP-9 mRNA stabilization and pro-
tein production in HuR KOmacrophages, we believe that,
on recruitment, adhesion, and transmigration, integrin-
triggered signals are initiated, but a major downstream
consequence, that of HuR-dependent posttranscriptional
Macrophage HuR-Dependent Angiogenesis 1759
AJP April 2012, Vol. 180, No. 4(mRNA stability) regulation, is defective. Limiting quanti-
ties of proangiogenic factors are produced, with reduc-
tion in induced neovessel formation and limb perfusion
recovery.
In addition to beneficial angiogenesis required in
adaptive responses to tissue ischemia and in wound
healing, pathologic angiogenesis driving tumor growth
and metastasis can also be macrophage dependent.
Monocyte-depleted mice have less-vascularized tu-
mors,39 and the degree of angiogenesis correlates with
the number of CD68-positive macrophages in human
tumors.40 Tumor-associated macrophages produce
VEGF and MMP-9, which are both required for full-ampli-
tude angiogenesis and the growth of some tumors.41
Furthermore, greater levels of cytoplasmic HuR correlate
with the aggressiveness and regional metastasis of some
breast cancers.42 It is likely that the link between macro-
phage recruitment/localization, signals driving HuR trans-
location, stabilization of otherwise labile transcripts en-
coding angiogenic molecules, macrophage production
of these soluble factors, and tumor angiogenesis follows
the same pattern as in the adaptive models.
Many of the potential angiogenic factors described
herein are encoded by ARE-bearing transcripts and, as
such, would also require similar posttranscriptional con-
trols. It is likely that a significant deficiency of multiple
macrophage-secreted factors plays a role in the impaired
responses we observed. We are currently characterizing
the spectrum of relevant macrophage transcripts that are
deficient in these models. The findings presented herein
are the first to document a role of posttranscriptional
mechanisms, mediated by a ubiquitous RNA-binding
protein and required selectively in macrophages, in
adaptive angiogenic responses, including that observed
in ischemia.
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